Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Author(s) -
Satoshi Inagaki,
Kazuhide Kawase,
Michinori Funato,
Junko Seki,
Chizuru Kawase,
Kazuki Ohuchi,
Tsubasa Kameyama,
Shiori Ando,
Arisu Sato,
Wataru Morozumi,
Shinsuke Nakamura,
Masamitsu Shimazawa,
Daisuke Iejima,
Takeshi Iwata,
Tetsuya Yamamoto,
Hideo Kaneko,
Hideaki Hara
Publication year - 2018
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-22975
Subject(s) - optineurin , timolol , induced pluripotent stem cell , microbiology and biotechnology , blot , autophagy , chemistry , glaucoma , apoptosis , biology , biochemistry , neuroscience , embryonic stem cell , gene
To determine a chemical agent that can reduce the aggregation of optineurin (OPTN) in cells differentiated from induced pluripotent stem cells obtained from a patient with normal-tension glaucoma (NTG) caused by an E50K mutation in the OPTN gene (OPTNE50K-NTG).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom